The potential value of nanomedicine and novel oral dosage forms in the treatment of HIV

Nanomedicine (Lond). 2018 Aug;13(16):1963-1965. doi: 10.2217/nnm-2018-0182. Epub 2018 Sep 6.

Authors

James J Hobson¹, Andrew Owen², Steve P Rannard¹

Affiliations

¹ Department of Chemistry, University of Liverpool, Crown Street, Liverpool, L69 7ZD, UK.
² Department of Molecular & Clinical Pharmacology, University of Liverpool, Pembroke Place, Liverpool, L69 3GF, UK.

PMID: 30188248
DOI: 10.2217/nnm-2018-0182

No abstract available

Keywords: HIV/AIDS; combination therapy; long acting; nanomedicine; oral dose; pediatrics; prophylaxis; sustained release.

Publication types

Editorial
Review

MeSH terms

Administration, Oral
Anti-HIV Agents / administration & dosage*
Anti-HIV Agents / therapeutic use*
HIV Infections / drug therapy*
Humans
Nanomedicine / methods*

Substances

Anti-HIV Agents